ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
09 Sep 2024 16:56

The Stocks to Own in Asia – Vol. 46

We highlight 14 stocks in Asia that look interesting to us based on our FVMR methodology. Portfolio changes: Two stock remains, 12 stocks added.

Share
09 Sep 2024 07:05

KRX Foreign Holding Weekly (Sep 6th): Samsung Electronics, Sk Hynix, Kia Corp.

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Sk Hynix, Kia Corp..

Logo
393 Views
Share
03 Sep 2024 16:15

Trading Plays on Samsung C&T’s Holding Company Shift and Biologics Share Sell-Off

This post explores trading angles triggered by Samsung C&T’s forced holding company conversion issue, caused by the rise in Samsung Biologics'...

Logo
651 Views
Share
bullishSamsung C&T
31 Aug 2024 17:44

Keep an Eye on Samsung C&T & SK Square as the Next Hot Picks for Value-Up Announcements

This post dives into the potential for Samsung C&T and SK Square to be the next big players in value-up announcements and explores the likely price...

Logo
655 Views
Share
26 Aug 2024 07:05

KRX Foreign Holding Weekly (Aug 23rd): Samsungelec, Sk Hynix, Hyundaimtr

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsungelec, Sk Hynix, Hyundaimtr.

Logo
340 Views
Share
x